An Explorative Analysis of <i>ABCG2/TOP-1</i> mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of t...

by Jan Stenvang, Eva Budinská, Eric van Cutsem, Fred Bosman, Vlad Popovici, Nils Brünner
Published 2020-04-01

Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review

by Dorte Lisbet Nielsen, Jesper Andreas Palshof, Nils Brünner, Jan Stenvang, Birgitte Martine Viuff
Published 2017-09-01

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase...

by Iben Kümler, Eva Balslev, Jan Stenvang, Nils Brünner, Bent Ejlertsen, Erik Hugger Jakobsen, Dorte Lisbet Nielsen
Published 2019-06-01

Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance

by Thiago S. Lima, Diego Iglesias-Gato, Luciano D.O. Souza, Jan Stenvang, Diego S. Lima, Martin A. Røder, Klaus Brasso, José M.A. Moreira
Published 2021-03-01

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer

by Peide Huang, Fengyu Li, Zongchao Mo, Chunyu Geng, Fang Wen, Chunyan Zhang, Jia Guo, Song Wu, Lin Li, Lin Li, Nils Brünner, Jan Stenvang
Published 2021-05-01

Metallopeptidase inhibitor 1 (TIMP‐1) promotes receptor tyrosine kinase c‐Kit signaling in colorectal cancer

by Cathrine Nordgaard, Sophia Doll, Ana Laura de Souza Almeida Matos, Mikkel Høeberg, Julhash Uddin Kazi, Stine Friis, Jan Stenvang, Lars Rönnstrand, Matthias Mann, José Manuel Afonso Moreira
Published 2019-12-01

Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment

by Anne-Marie Ellegaard, Christian Dehlendorff, Anna C. Vind, Atul Anand, Luise Cederkvist, Nikolaj H.T. Petersen, Jesper Nylandsted, Jan Stenvang, Anders Mellemgaard, Kell Østerlind, Søren Friis, Marja Jäättelä
Published 2016-07-01

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP

by Sophie E. B. Ambjørner, Michael Wiese, Sebastian Christoph Köhler, Joen Svindt, Xamuel Loft Lund, Michael Gajhede, Lasse Saaby, Birger Brodin, Steffen Rump, Henning Weigt, Nils Brünner, Jan Stenvang
Published 2020-03-01

Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.

by Erika Assarsson, Martin Lundberg, Göran Holmquist, Johan Björkesten, Stine Bucht Thorsen, Daniel Ekman, Anna Eriksson, Emma Rennel Dickens, Sandra Ohlsson, Gabriella Edfeldt, Ann-Catrin Andersson, Patrik Lindstedt, Jan Stenvang, Mats Gullberg, Simon Fredriksson
Published 2014-01-01

miRNA profiling of circulating EpCAM+ extracellular vesicles: promising biomarkers of colorectal cancer

by Marie Stampe Ostenfeld, Steffen Grann Jensen, Dennis Kjølhede Jeppesen, Lise-Lotte Christensen, Stine Buch Thorsen, Jan Stenvang, Michael Lykke Hvam, Anni Thomsen, Peter Mouritzen, Mads Heilskov Rasmussen, Hans Jørgen Nielsen, Torben Falck Ørntoft, Claus Lindbjerg Andersen
Published 2016-08-01

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer

by Jesper Andreas Palshof, Camilla Natasha Cederbye, Estrid Vilma Solyom Høgdall, Tim Svenstrup Poulsen, Dorte Linnemann, Sune Boris Nygaard, Jan Stenvang, Ib Jarle Christensen, Benny Vittrup Jensen, Per Pfeiffer, Nils Brünner, Mette Yilmaz, Birgitte Martine Viuff, Dorte Lisbet Nielsen
Published 2020-07-01